Post-COVID-19 severe neutropenia.

Szczegóły

Tytuł:: Post-COVID-19 severe neutropenia.
Autorzy:: Bouslama B; Laboratory of Haematology, AP-HP, Hôpital Armand Trousseau, DMU BioGeM, Paris, France.
Pierret C; General Pediatrics Department, Hôpital Saint Camille, Bry-sur-Marne, France.
Khelfaoui F; General Pediatrics Department, Hôpital Saint Camille, Bry-sur-Marne, France.
Bellanné-Chantelot C; Department of Genetics, AP-HP, Hôpital Pitié-Salpêtrière, DMU BioGeM, Paris, France.
Donadieu J; Pediatric Hematology and Oncology Department, AP-HP, Hôpital Armand Trousseau, DMU ORIGYNE, Sorbonne Université, Paris, France.
Héritier S; Pediatric Hematology and Oncology Department, AP-HP, Hôpital Armand Trousseau, DMU ORIGYNE, Sorbonne Université, Paris, France.
Źródło:: Pediatric blood & cancer [Pediatr Blood Cancer] 2021 May; Vol. 68 (5), pp. e28866. Date of Electronic Publication: 2020 Dec 23.
Typ publikacji:: Case Reports; Letter
Język:: English
Imprint Name(s):: Original Publication: Hoboken, N.J. : John Wiley, c 2004-
MeSH Terms:: COVID-19/*pathology
Filgrastim/*therapeutic use
Hematologic Agents/*therapeutic use
Neutropenia/*drug therapy
Neutropenia/*virology
Antibodies, Viral/blood ; Humans ; Immunoglobulin G/blood ; Immunoglobulin M/blood ; Infant ; Leukocyte Count ; Male ; Neutropenia/pathology ; Neutrophils/cytology ; SARS-CoV-2
References:: Lancet Child Adolesc Health. 2021 Feb;5(2):133-141. (PMID: 32956615)
Am J Hematol. 2020 Jun;95(6):E131-E134. (PMID: 32129508)
Int J Lab Hematol. 2020 Jun;42 Suppl 1:11-18. (PMID: 32311826)
Br J Haematol. 2017 Nov;179(4):557-574. (PMID: 28875503)
Acta Paediatr. 2021 Mar;110(3):922-932. (PMID: 33190340)
Substance Nomenclature:: 0 (Antibodies, Viral)
0 (Hematologic Agents)
0 (Immunoglobulin G)
0 (Immunoglobulin M)
PVI5M0M1GW (Filgrastim)
Entry Date(s):: Date Created: 20201228 Date Completed: 20210406 Latest Revision: 20221005
Update Code:: 20240105
PubMed Central ID:: PMC7883096
DOI:: 10.1002/pbc.28866
PMID:: 33355971
: Raport

Full Text Finder

Informacja